Abstract
It has been demonstrated convincingly that ACTH and prolactin release are under the stimulatory control of serotonin (5-hydroxytryptamine, 5HT). Recent animal studies suggest that stimulation of 5HT activity also induces the release of arginine-vasopressin (AVP). More specifically, m-chlorophenylpiperazine (MCPP), a 5HT agonist widely used to examine 5HT receptor responsivity in human subjects, has been found to induce AVP release in rodents. This study examined whether MCPP increased plasma AVP levels in healthy human subjects. MCPP was administered orally to 17 healthy subjects in a placebo-controlled design in doses of 0.25 and 0.5 mg/kg. AVP was measured twice hourly over a 210 min period after administration of capsules. MCPP did not significantly alter AVP levels as compared to placebo. However, female subjects had significantly lower plasma AVP levels than males. Since it has been suggested that MCPP-induced AVP release in animals is due to stimulation of 5HT1c receptors, the fact that MCPP did not induce the release of AVP in humans suggests that either MCPP is not a potent 5HT1c agonist or that AVP is not released by stimulation of 5HT(1c) receptors in human subjects. The observation of gender differences in plasma AVP levels suggests that this factor should be taken into account in future studies of AVP secretion in plasma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bagdy G, Calogero AE, Szemeredi K, Gomez MT, Murphy DL, Chrousos GP, Gold PW (1990) β-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action. Brain Res 537:227–232
Brownfield MS, Greathouse J, Lorens, SA, Armstrong J, Urban JH, Van de Kar LD (1988) Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology 47:277–283
Calogero AE, Bagdy G, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP (1990) Mechanism of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 126:1888–1894
Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Hillsdale, NJ
DiRenzo G, Amoroso S, Taglialatela M, Canzoniero L, Basile V, Fatatis A, Annunziato L (1989) Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion. Eur J Pharmacol 162:371–373
Gibbs DM, Vale W (1983) Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain Res 280:176–179
Gilbert F, Dourish CT, Brazell C, McClue S, Stahl SM (1988) Relationship of increased food intake and plasma ACTH levels to 5HT1a receptor activation in rats. Psychoneuroendocrinology 13:471–478
Kahn RS, Wetzler S (1991) m-Chlorophenylpiperazine as a probe of serotonin receptors: a review. Biol Psychiatry 30:1139–1166
Kahn RS, Wetzler, S, Asnis GM, van Praag HM (1990) The effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology 100:339–344
Kahn RS, Wetzler S, Asnis GM, van Praag HM (1991) Pituitary hormone responses to m-chlorophenylpiperazine in patients with panic disorder and healthy subjects. Psychiatry Res 37:25–34
Kalus O, Wetzler S, Kahn RS, Asnis GM, van Praag HM (1992) A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects. Psychopharmacology 106:388–390
King KA, Courneya CA, Tang C, Wilson N, Ledsome JR (1989) Pharmacokinetics of vasopressin and atrial natriuretic peptide in anaesthetized rabbits. Endocrinology 124:77–83
Koenig JI, Gudelsky GA, Meltzer HY (1987) Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5HT receptor subtype activation. Eur J Pharmacol 137:1–8
Lesch KP, Mayer S, Disselkamp-Tietze J, Hoh A, Schoellnhammer G, Schulte HM (1990) Subsensitivity of the 5-hydroxytryptaminelA (5-HT1A) receptor-mediated hypothermic response to ipsairone in unipolar depression. Life Sci 46:1271–1277
Montes R, Johnson AK (1990) Efferent mechanisms mediating renal sodium and water excretion induced by centrally administered serotonin. Am J Physiol 28:1267–1273
Mueller EA, Sunderland T, Murphy DL (1985) Neuroendocrine effects of m-CPP, a serotonin agonist, in humans. J Clin Endocrinol Metab 61:1179–1184
Murphy DL, Mueller EA, Garrick NA, Aulakh CS (1986) Use of serotonergic agents in the clinical assessment of central serotonin function. J Clin Psychiatry 47:9–15
Murphy DL, Mueller EA, Hill JL, Tolliver TJ, Jacobsen FM (1989) Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology 98:275–282
Rittmaster RS, Cutler GB, Gold PW, Brandon DD, Tomai TP, Chrousos GP (1987) The relationship of saline-induced changes in vasopressin secretion to basal and corticotropinreleasing hormone-stimulated adrenocorticotropin and cortisol secretion in man. J Clin Endocrinol Metab 64:371–376
Stark H, Burbach JP, Van der Kleij AA, De Wied D (1989) In vivo conversion of vasopressin after microinjection into limbic brain. Peptides 10:717–720
Steardo L, Iovino M (1986) Vasopressin release after enhanced serotonergic transmission is not due to activation of the peripheral renin-angiotensin system. Brain Res 382:145–148
Tuomisto J, Männistö (1985) Neurotransmittor regulation of anterior pituitary hormones. Pharmacol Rev 37:249–332
van Praag HM, Lemus CZ, Kahn RS (1987) Hormonal probes of central serotonergic activity: do they really exist? Biol Psychiatry 22:86–98
Willoughby JO, Menadue MF, Liebelt HJ (1988) Activation of 5HT-1 serotonin receptors in the medial basal hypothalamus stimulates prolactin secretion in the unanaesthetized rat. Neuroendocrinology 47:83–87
Author information
Authors and Affiliations
Additional information
This work was conducted at the Department of Psychiatry, Montefiore Hospital/Albert Einstein College of Medicine, New York, NY, USA
Rights and permissions
About this article
Cite this article
Kahn, R.S., Kling, M.A., Wetzler, S. et al. Effect of m-chlorophenylpiperazine on plasma arginine-vasopressin concentrations in healthy subjects. Psychopharmacology 108, 225–228 (1992). https://doi.org/10.1007/BF02245312
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245312